SolveBio Awarded Phase I SBIR Grant to Develop Variant Analysis Tool | GenomeWeb

NEW YORK (GenomeWeb) – Genomics data infrastructure provider SolveBio announced today that it has received a $223,181 Phase I Small Business Innovation Research Grant from the National Institute of General Medical Sciences to develop a genetic variation analysis and visualization system called Variant Explorer.

The company said it will use the funds to develop the Variant Explorer to serve as a tool that clinical geneticists, molecular pathologists, and pharmaceutical industry and academic researchers can use to make clinical decisions for patients requiring a genetic diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.